New benchmarks for the wholesale pricing of prescription drugs are now in effect, and payors are now struggling to determine how the changes will affect them. Health plans and pharmacy benefit managers alike must now pay careful attention to pricing methodologies and must maintain an open dialogue with one another to ensure pricing consistency and transparency.
